文献速递甲状腺疾病

老年人医源性甲状腺毒症风险的性别差异:基于真实世界临床数据的分析

Sex Differences in Risk for Iatrogenic Thyrotoxicosis Among Older Adults: An Analysis from Real-World Clinical Data.
PubMed 文献 · Thyroid · 2025-03-21

这项回顾性队列研究纳入美国大型社区健康系统50岁及以上成人20724例,分析医源性甲状腺毒症与性别的关系。女性低促甲状腺激素(TSH)比例高于男性(36.7% vs 23.9%),未调整风险比HR=1.67。按去脂体重计算剂量后性别风险差异消失(HR=1.06),提示体成分差异可能解释该风险。

要点

  • 女性低TSH比例36.7%,高于男性23.9%,未调整HR=1.67。
  • 按实际体重调整剂量后女性HR=1.50,与未调整剂量模型无差异(p=0.422)。
  • 按去脂体重计算剂量后性别风险差异完全中介(HR=1.06)。

核心结论

  • 中介分析表明老年女性医源性甲状腺毒症风险增加可能归因于男女体成分差异。
  • 使用理想体重或去脂体重剂量计算器替代实际体重给药,可能降低老年女性这一潜在医源性甲状腺毒症风险来源。

研究设计与样本

  • 回顾性队列研究,使用美国大型社区健康系统电子健康记录,纳入50岁及以上成人。
  • 共20724例患者符合全部纳入标准,其中女性77%,非白人23%。
  • 调整人口学、合并症、体成分和甲状腺激素剂量。

主要发现

  • 女性低TSH比例36.7%,男性23.9%;未调整HR=1.67(95%CI 1.56-1.79)。
  • 左甲状腺素每日剂量中位数按实际体重:男性1.1 μg/kg,女性1.2 μg/kg(p<0.001)。
  • 调整除剂量外的协变量未显著改变性别相关医源性甲状腺毒症风险。
  • 完全调整模型(含实际体重剂量)女性vs男性HR=1.50(95%CI 1.34-1.69),与未含剂量模型无差异(p=0.422)。
  • 按理想体重剂量调整后部分中介(HR=1.30,95%CI 1.16-1.46;p<0.001);按去脂体重剂量完全中介(HR=1.06,95%CI 0.95-1.19;p<0.001)。

临床怎么用

  • 作者认为,使用理想体重或去脂体重剂量计算器替代实际体重给药,可能降低老年女性医源性甲状腺毒症风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Overtreatment with thyroid hormone is common and is associated with multiple adverse health outcomes, especially in older adults. Higher overtreatment rates have been reported among women. Understanding this sex difference could lead to better clinical utilization of therapy in at-risk populations. Methods: We performed a retrospective cohort study to examine the relationship between iatrogenic thyrotoxicosis and patient sex, adjusting for demographics, comorbidities, body composition, and thyroid hormone dosing using electronic health records for adults age 50 and older in a large community health system in the United States. Results: A total of 20,724 patients met all inclusion criteria, of whom 77% were female and 23% non-White. Women were more likely to have a low thyrotropin (TSH) compared to men (36.7% vs. 23.9%; unadjusted hazard ratio [HR] = 1.67 [95% confidence interval {CI} 1.56-1.79]). Many covariates varied by sex, including rates of several comorbidities, and there was a small but statistically significant difference in the median daily levothyroxine dose per actual body mass: 1.1 μg/kg in male patients compared with 1.2 μg/kg in female patients (p < 0.001). Adjusting for covariates other than dose did not significantly change the sex-related risk of iatrogenic thyrotoxicosis. In fully adjusted Cox models including dose per actual body mass, the female versus male HR = 1.50 [CI 1.34-1.69] was also not different from models which did not account for dose (p = 0.422). However, the association between female sex and thyrotoxicosis risk was partially mediated when adjusting for dose per ideal body mass (HR = 1.30 [CI: 1.16-1.46]; p < 0.001) and was fully mediated by dose calculated using lean body mass (HR = 1.06 [CI: 0.95-1.19]; p < 0.001). That is, women had higher risk of iatrogenic thyrotoxicosis compared to men receiving similar actual body mass doses, whereas women and men receiving comparable lean body mass doses had comparable risk. Conclusions: Mediation analysis demonstrates that the increased risk of iatrogenic thyrotoxicosis in older women may be attributable to differences in body composition between men and women. The use of ideal or lean body weight-based dose calculators in place of actual body weight dosing could reduce this potential source of iatrogenic thyrotoxicosis risk in older women.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Adams R, Mammen JS. Sex Differences in Risk for Iatrogenic Thyrotoxicosis Among Older Adults: An Analysis from Real-World Clinical Data. Thyroid. 2025. PMID: 40117123. doi:10.1089/thy.2024.0604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。